论文部分内容阅读
浙江钱江生物化学股份有限公司出资2790万元受让北京美生科贸有限公司原第一大股东——深圳健鹏投资有限公司持有的美生公司1860万元出资额,出资转让后,钱江生化占美生公司注册资本的50.54%,成为美生公司第一大股东。出资转让协议日前正式签署。美生公司有着强大的全球综合资源优势及网络建设,并与美国美生集团和以美国卫德营养国际集团为首的十余家保健品领域的
Zhejiang Qianjiang Biochemical Co., Ltd. invested 27.9 million yuan to transfer the amount of 18.6 million yuan invested by Meisheng Co., Ltd., the original largest shareholder of Beijing Meisheng Electronics Co., Ltd., held by Shenzhen Jianpeng Investment Co., Ltd. Qianjiang Biochemical accounted for 50.54% of the registered capital of the company, becoming the largest shareholder of the company. The capital transfer agreement was officially signed a few days ago. The United States and the United States has a strong global comprehensive resource advantage and network construction, and with the United States and the United States Health Group and the United States Wei De Nutrition International Group, led by more than a dozen health products field